Table 4.
Prior Case Reports and Case Series Reporting MitraClip Use in Cardiogenic Shock
| Study | No. | Age (y) | Women | STS PROM (%) | Prior MI | On MCS | Primary MR | DOA to MitraClip (d) | LOS (d) | In‐Hospital Mortality | Follow‐Up (mo) | Follow‐Up Mortality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zuern CS et al (2011) 4 | 1 | 51 | 0 | … | 1 | 1 | 0 | 10 | 17 | 0 | 3 | 0 |
| Pleger ST et al (2013) 5 | 6 | 68.7 [7.6] | 1 (17%) | 27.3 [21.4] | 5 (83%) | 0 |
2 (33%) Mixed |
41.2 [41.6] {10–113} |
53.7 [41.1] {13–119} |
0 | … | … |
| Couture P et al (2014) 6 | 1 | 78 | 0 | 83 | 1 | 1 | 0 | 60 | 81 | 0 | 12 | 0 |
| Wolff R et al (2014) 7 | 1 | 68 | 0 | 64 | 1 | 1 | 1 | 1 | 14 | 0 | 6 | 0 |
| Bahlmann E et al (2015) 8 | 1 | 77 | 0 | 78* | 1 | 1 | 1 | … | 16 | 0 | … | … |
| Tang GHL et al (2018) 9 | 1 | 77 | 1 | … | 0 | 1 | 1 | … | 15 | 0 | 9 | 0 |
| Buckert D et al (2017) 10 | 1 | 78 | 0 | 18.4 | 1 | 1 | 1 | … | 14 | 0 | 4 | 0 |
| Hernandez M et al (2018) 11 | 1 | 70 | 0 | 7.1 | 1 | 1 |
1 Mixed |
3 | 33 | 0 | 6 | 0 |
| Haberman D et al (2019) 12 | 20 | 68.1 [9.9] | 14 (70%) | … | 20 (100%) | 7 | 0 |
32 [25] {7–90} |
… | 1 (5%) |
Median, 15 {3–88} |
2 |
| Rizik DG et al (2019) 13 | 3 | 72, 92, 81 | 0 | … | 1 (33%) | 2 | 2 (67%) | … |
7, 3, 4 Post‐op |
0 | 1 | 0 |
| Chan V et al (2019) 14 | 27 | 71 [13] | 10 (37%) | 18.5 | 5 (19%) | 5 | 2 |
Median, 23 (9–37) |
Median, 40 {22–70} Post‐op |
8 (30%) | 6.7 [8.9] | 17 (63%) |
| Cheng R et al (2019) 15 | 29 | 65.5 [17.0] | 5 (17%) | … | 10 (35%) | 8 (28%) | … | … | … | 5 (17%) | 14.8 [15.7] | 7 (24%) |
| Flint K et al (2019) 16 | 12 | 71.7 [12.8] | 3 (25%) | 23.9 [18.2] | 4 (33%) | 5 (42%) |
10 (83%) 6 Mixed |
… | … | 1 (8%) |
Median, 6.6 {1.4–12.6} |
5 (42%) |
| Garcia S et al (2020) 17 | 11 | 74.5 [13.3] | 5 (45%) |
15.5 [IQR, 6.9–39.1] |
5 (45%) | 5 (45%) | 7 (64%) | … | … | 3/11 (27%) | 12 | 6/9 (66%) |
| Estevez‐Loureiro R et al (2020) 18 | 44 | 70.0 [10.8] | 16 (36%) | 15.1 {6.2–23.2} | 44 (100%) | 16 (36%) | 44 (10%) | Median, 18 {13–36.8} |
Median, 16 {8–27} Post‐op |
4 (9%) | 6 | 8 (18%) |
All variables expressed as n (%), mean (SD), (range) , and interquartile range. DOA indicates date of admission; IQR, interquartile range; LOS, length of stay; MCS, mechanical circulatory support; MI, myocardial infarction; MR, mitral regurgitation; PCI, percutaneous coronary intervention; and STS PROM, Society of Thoracic Surgeons predicted risk of operative mortality.
*
EuroScore listed, as STS PROM score was not available.